Principal Financial Group Inc Inovio Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$0.35 - $0.53 $2,456 - $3,719	7,018 Added 11.44%	68,349 $34,000
Q2 2023 Aug 07, 2023	SELL	$0.39 - $0.94 $3,046 - $7,343	-7,812 Reduced 11.3%	61,331 $27,000
Q1 2023 May 09, 2023	BUY	$0.79 - $1.91 $7,444 - $17,999	9,424 Added 15.78%	69,143 $56,000
Q4 2022 Feb 09, 2023	BUY	$1.41 - $2.5 $14,365 - $25,470	10,188 Added 20.57%	59,719 $93,000
Q3 2022 Nov 09, 2022	BUY	$1.66 - $2.79 $24,061 - $40,441	14,495 Added 41.37%	49,531 $85,000
Q2 2022 Aug 10, 2022	SELL	$1.44 - $3.98 $7,716 - $21,328	-5,359 Reduced 13.27%	35,036 $61,000
Q1 2022 May 09, 2022	SELL	$2.97 - $5.2 $8,313 - $14,554	-2,799 Reduced 6.48%	40,395 $145,000
Q4 2021 Feb 09, 2022	SELL	$4.99 - $7.46 $76,506 - $114,376	-15,332 Reduced 26.2%	43,194 $216,000
Q3 2021 Nov 09, 2021	SELL	$7.16 - $9.69 $93,516 - $126,561	-13,061 Reduced 18.24%	58,526 $419,000
Q2 2021 Aug 10, 2021	SELL	$6.23 - $10.03 $31,997 - $51,514	-5,136 Reduced 6.69%	71,587 $663,000
Q1 2021 May 10, 2021	BUY	$8.81 - $16.96 $14,924 - $28,730	1,694 Added 2.26%	76,723 $712,000
Q4 2020 Feb 08, 2021	BUY	$8.5 - $12.85 $259,751 - $392,683	30,559 Added 68.72%	75,029 $664,000
Q3 2020 Nov 06, 2020	SELL	$9.57 - $27.05 $10,584 - $29,917	-1,106 Reduced 2.43%	44,470 $515,000
Q2 2020 Aug 05, 2020	BUY	$7.14 - $31.69 $240,132 - $1.07 Million	33,632 Added 281.58%	45,576 $1.23 Million
Q1 2020 May 12, 2020	SELL	$2.98 - $14.09 $3,552 - $16,795	-1,192 Reduced 9.07%	11,944 $89,000
Q4 2019 Feb 05, 2020	SELL	$1.97 - $3.72 $30,824 - $58,206	-15,647 Reduced 54.36%	13,136 $43,000
Q3 2019 Nov 13, 2019	BUY	$2.05 - $3.02 $5,436 - $8,009	2,652 Added 10.15%	28,783 $59,000
Q2 2019 Aug 12, 2019	BUY	$2.29 - $4.1 $3,748 - $6,711	1,637 Added 6.68%	26,131 $77,000
Q1 2019 May 10, 2019	BUY	$3.34 - $5.1 $1,135 - $1,733	340 Added 1.41%	24,494 $92,000
Q4 2018 Feb 14, 2019	SELL	$3.89 - $6.11 $19,691 - $30,928	-5,062 Reduced 17.33%	24,154 $97,000
Q3 2018 Nov 14, 2018	BUY	$3.92 - $5.58 $14,057 - $20,009	3,586 Added 13.99%	29,216 $162,000
Q2 2018 Aug 13, 2018	SELL	$3.88 - $5.16 $5,645 - $7,507	-1,455 Reduced 5.37%	25,630 $0
Q1 2018 May 14, 2018	SELL	$4.05 - $5.69 $1,741 - $2,446	-430 Reduced 1.56%	27,085 $127,000
Q4 2017 Feb 13, 2018	BUY	$4.13 - $6.68 $70,461 - $113,967	17,061 Added 163.2%	27,515 $114,000
Q3 2017 Nov 02, 2017	BUY	$5.36 - $6.37 $56,033 - $66,591	10,454	10,454 $66,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account